Click for best price
Cardiovascular DrugEluting StentsDES Market Size, Share 2024
The global Cardiovascular Drug-Eluting Stents(DES) market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Passive Coating Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cardiovascular Drug-Eluting Stents(DES) include MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin and Terumo Medical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Drug-Eluting Stents(DES), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Drug-Eluting Stents(DES). This report contains market size and forecasts of Cardiovascular Drug-Eluting Stents(DES) in global, including the following market information:
Global Cardiovascular Drug-Eluting Stents(DES) Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Cardiovascular Drug-Eluting Stents(DES) Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Cardiovascular Drug-Eluting Stents(DES) companies in 2023 (%)
We surveyed the Cardiovascular Drug-Eluting Stents(DES) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiovascular Drug-Eluting Stents(DES) Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) Market Segment Percentages, by Type, 2023 (%)
Passive Coating
Active Coating
Global Cardiovascular Drug-Eluting Stents(DES) Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Global Cardiovascular Drug-Eluting Stents(DES) Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiovascular Drug-Eluting Stents(DES) revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Cardiovascular Drug-Eluting Stents(DES) revenues share in global market, 2023 (%)
Key companies Cardiovascular Drug-Eluting Stents(DES) sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Cardiovascular Drug-Eluting Stents(DES) sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Boston Scientific
MicroPort Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiovascular Drug-Eluting Stents(DES), market overview.
Chapter 2: Global Cardiovascular Drug-Eluting Stents(DES) market size in revenue and volume.
Chapter 3: Detailed analysis of Cardiovascular Drug-Eluting Stents(DES) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiovascular Drug-Eluting Stents(DES) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cardiovascular Drug-Eluting Stents(DES) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cardiovascular Drug-Eluting Stents(DES) Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
117 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cardiovascular Drug-Eluting Stents(DES) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cardiovascular Drug-Eluting Stents(DES) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cardiovascular Drug-Eluting Stents(DES) Overall Market Size
2.1 Global Cardiovascular Drug-Eluting Stents(DES) Market Size: 2023 VS 2030
2.2 Global Cardiovascular Drug-Eluting Stents(DES) Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Cardiovascular Drug-Eluting Stents(DES) Sales: 2019-2030
3 Company Landscape
3.1 Top Cardiovascular Drug-Eluting Stents(DES) Players in Global Market
3.2 Top Global Cardiovascular Drug-Eluting Stents(DES) Companies Ranked by Revenue
3.3 Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Companies
3.4 Global Cardiovascular Drug-Eluting Stents(DES) Sales by Companies
3.5 Global Cardiovascular Drug-Eluting Stents(DES) Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Cardiovascular Drug-Eluting Stents(DES) Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Cardiovascular Drug-Eluting Stents(DES) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cardiovascular Drug-Eluting Stents(DES) Players in Global Market
3.8.1 List of Global Tier 1 Cardiovascular Drug-Eluting Stents(DES) Companies
3.8.2 List of Global Tier 2 and Tier 3 Cardiovascular Drug-Eluting Stents(DES) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Market Size Markets, 2023 & 2030
4.1.2 Passive Coating
4.1.3 Active Coating
4.2 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Revenue & Forecasts
4.2.1 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2024
4.2.2 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, 2025-2030
4.2.3 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
4.3 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Sales & Forecasts
4.3.1 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Sales, 2019-2024
4.3.2 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Sales, 2025-2030
4.3.3 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
4.4 By Type - Global Cardiovascular Drug-Eluting Stents(DES) Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Revenue & Forecasts
5.2.1 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2024
5.2.2 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, 2025-2030
5.2.3 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
5.3 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Sales & Forecasts
5.3.1 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Sales, 2019-2024
5.3.2 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Sales, 2025-2030
5.3.3 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
5.4 By Application - Global Cardiovascular Drug-Eluting Stents(DES) Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Market Size, 2023 & 2030
6.2 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue & Forecasts
6.2.1 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2024
6.2.2 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, 2025-2030
6.2.3 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
6.3 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Sales & Forecasts
6.3.1 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Sales, 2019-2024
6.3.2 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Sales, 2025-2030
6.3.3 By Region - Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2030
6.4.2 By Country - North America Cardiovascular Drug-Eluting Stents(DES) Sales, 2019-2030
6.4.3 US Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.4.4 Canada Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.4.5 Mexico Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2030
6.5.2 By Country - Europe Cardiovascular Drug-Eluting Stents(DES) Sales, 2019-2030
6.5.3 Germany Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.5.4 France Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.5.5 U.K. Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.5.6 Italy Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.5.7 Russia Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.5.8 Nordic Countries Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.5.9 Benelux Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2030
6.6.2 By Region - Asia Cardiovascular Drug-Eluting Stents(DES) Sales, 2019-2030
6.6.3 China Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.6.4 Japan Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.6.5 South Korea Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.6.6 Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.6.7 India Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2030
6.7.2 By Country - South America Cardiovascular Drug-Eluting Stents(DES) Sales, 2019-2030
6.7.3 Brazil Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.7.4 Argentina Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales, 2019-2030
6.8.3 Turkey Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.8.4 Israel Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.8.5 Saudi Arabia Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
6.8.6 UAE Cardiovascular Drug-Eluting Stents(DES) Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 MIV Therapeutics
7.1.1 MIV Therapeutics Company Summary
7.1.2 MIV Therapeutics Business Overview
7.1.3 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.1.4 MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.1.5 MIV Therapeutics Key News & Latest Developments
7.2 Orbusneich
7.2.1 Orbusneich Company Summary
7.2.2 Orbusneich Business Overview
7.2.3 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.2.4 Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.2.5 Orbusneich Key News & Latest Developments
7.3 Promed Medical
7.3.1 Promed Medical Company Summary
7.3.2 Promed Medical Business Overview
7.3.3 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.3.4 Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.3.5 Promed Medical Key News & Latest Developments
7.4 Relisys Medical
7.4.1 Relisys Medical Company Summary
7.4.2 Relisys Medical Business Overview
7.4.3 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.4.4 Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.4.5 Relisys Medical Key News & Latest Developments
7.5 Reva Medical
7.5.1 Reva Medical Company Summary
7.5.2 Reva Medical Business Overview
7.5.3 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.5.4 Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.5.5 Reva Medical Key News & Latest Developments
7.6 Sahajanand
7.6.1 Sahajanand Company Summary
7.6.2 Sahajanand Business Overview
7.6.3 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.6.4 Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.6.5 Sahajanand Key News & Latest Developments
7.7 Sino Medical
7.7.1 Sino Medical Company Summary
7.7.2 Sino Medical Business Overview
7.7.3 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.7.4 Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.7.5 Sino Medical Key News & Latest Developments
7.8 Sorin
7.8.1 Sorin Company Summary
7.8.2 Sorin Business Overview
7.8.3 Sorin Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.8.4 Sorin Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.8.5 Sorin Key News & Latest Developments
7.9 Terumo Medical
7.9.1 Terumo Medical Company Summary
7.9.2 Terumo Medical Business Overview
7.9.3 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.9.4 Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.9.5 Terumo Medical Key News & Latest Developments
7.10 Abbott Vascular
7.10.1 Abbott Vascular Company Summary
7.10.2 Abbott Vascular Business Overview
7.10.3 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.10.4 Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.10.5 Abbott Vascular Key News & Latest Developments
7.11 Advantec Vascular
7.11.1 Advantec Vascular Company Summary
7.11.2 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Business Overview
7.11.3 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.11.4 Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.11.5 Advantec Vascular Key News & Latest Developments
7.12 B.Braun Melsengen AG
7.12.1 B.Braun Melsengen AG Company Summary
7.12.2 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Business Overview
7.12.3 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.12.4 B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.12.5 B.Braun Melsengen AG Key News & Latest Developments
7.13 Biosensors
7.13.1 Biosensors Company Summary
7.13.2 Biosensors Cardiovascular Drug-Eluting Stents(DES) Business Overview
7.13.3 Biosensors Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.13.4 Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.13.5 Biosensors Key News & Latest Developments
7.14 Boston Scientific
7.14.1 Boston Scientific Company Summary
7.14.2 Boston Scientific Business Overview
7.14.3 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.14.4 Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.14.5 Boston Scientific Key News & Latest Developments
7.15 MicroPort Medical
7.15.1 MicroPort Medical Company Summary
7.15.2 MicroPort Medical Business Overview
7.15.3 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Major Product Offerings
7.15.4 MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales and Revenue in Global (2019-2024)
7.15.5 MicroPort Medical Key News & Latest Developments
8 Global Cardiovascular Drug-Eluting Stents(DES) Production Capacity, Analysis
8.1 Global Cardiovascular Drug-Eluting Stents(DES) Production Capacity, 2019-2030
8.2 Cardiovascular Drug-Eluting Stents(DES) Production Capacity of Key Manufacturers in Global Market
8.3 Global Cardiovascular Drug-Eluting Stents(DES) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cardiovascular Drug-Eluting Stents(DES) Supply Chain Analysis
10.1 Cardiovascular Drug-Eluting Stents(DES) Industry Value Chain
10.2 Cardiovascular Drug-Eluting Stents(DES) Upstream Market
10.3 Cardiovascular Drug-Eluting Stents(DES) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cardiovascular Drug-Eluting Stents(DES) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Cardiovascular Drug-Eluting Stents(DES) in Global Market
Table 2. Top Cardiovascular Drug-Eluting Stents(DES) Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Cardiovascular Drug-Eluting Stents(DES) Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Cardiovascular Drug-Eluting Stents(DES) Revenue Share by Companies, 2019-2024
Table 5. Global Cardiovascular Drug-Eluting Stents(DES) Sales by Companies, (K Units), 2019-2024
Table 6. Global Cardiovascular Drug-Eluting Stents(DES) Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Cardiovascular Drug-Eluting Stents(DES) Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Cardiovascular Drug-Eluting Stents(DES) Product Type
Table 9. List of Global Tier 1 Cardiovascular Drug-Eluting Stents(DES) Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cardiovascular Drug-Eluting Stents(DES) Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Cardiovascular Drug-Eluting Stents(DES) Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Cardiovascular Drug-Eluting Stents(DES) Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), 2019-2024
Table 15. By Type - Global Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), 2025-2030
Table 16. By Application ? Global Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Cardiovascular Drug-Eluting Stents(DES) Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Cardiovascular Drug-Eluting Stents(DES) Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), 2019-2024
Table 20. By Application - Global Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), 2025-2030
Table 21. By Region ? Global Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), 2019-2024
Table 25. By Region - Global Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), 2025-2030
Table 26. By Country - North America Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2019-2024
Table 29. By Country - North America Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2025-2030
Table 30. By Country - Europe Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2019-2024
Table 33. By Country - Europe Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2025-2030
Table 34. By Region - Asia Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2019-2024
Table 37. By Region - Asia Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2025-2030
Table 38. By Country - South America Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2019-2024
Table 41. By Country - South America Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales, (K Units), 2025-2030
Table 46. MIV Therapeutics Company Summary
Table 47. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 48. MIV Therapeutics Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. MIV Therapeutics Key News & Latest Developments
Table 50. Orbusneich Company Summary
Table 51. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 52. Orbusneich Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Orbusneich Key News & Latest Developments
Table 54. Promed Medical Company Summary
Table 55. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 56. Promed Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Promed Medical Key News & Latest Developments
Table 58. Relisys Medical Company Summary
Table 59. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 60. Relisys Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Relisys Medical Key News & Latest Developments
Table 62. Reva Medical Company Summary
Table 63. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 64. Reva Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Reva Medical Key News & Latest Developments
Table 66. Sahajanand Company Summary
Table 67. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 68. Sahajanand Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Sahajanand Key News & Latest Developments
Table 70. Sino Medical Company Summary
Table 71. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 72. Sino Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Sino Medical Key News & Latest Developments
Table 74. Sorin Company Summary
Table 75. Sorin Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 76. Sorin Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Sorin Key News & Latest Developments
Table 78. Terumo Medical Company Summary
Table 79. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 80. Terumo Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Terumo Medical Key News & Latest Developments
Table 82. Abbott Vascular Company Summary
Table 83. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 84. Abbott Vascular Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Abbott Vascular Key News & Latest Developments
Table 86. Advantec Vascular Company Summary
Table 87. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 88. Advantec Vascular Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Advantec Vascular Key News & Latest Developments
Table 90. B.Braun Melsengen AG Company Summary
Table 91. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 92. B.Braun Melsengen AG Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. B.Braun Melsengen AG Key News & Latest Developments
Table 94. Biosensors Company Summary
Table 95. Biosensors Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 96. Biosensors Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Biosensors Key News & Latest Developments
Table 98. Boston Scientific Company Summary
Table 99. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 100. Boston Scientific Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Boston Scientific Key News & Latest Developments
Table 102. MicroPort Medical Company Summary
Table 103. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Product Offerings
Table 104. MicroPort Medical Cardiovascular Drug-Eluting Stents(DES) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. MicroPort Medical Key News & Latest Developments
Table 106. Cardiovascular Drug-Eluting Stents(DES) Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 107. Global Cardiovascular Drug-Eluting Stents(DES) Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Cardiovascular Drug-Eluting Stents(DES) Production by Region, 2019-2024 (K Units)
Table 109. Global Cardiovascular Drug-Eluting Stents(DES) Production by Region, 2025-2030 (K Units)
Table 110. Cardiovascular Drug-Eluting Stents(DES) Market Opportunities & Trends in Global Market
Table 111. Cardiovascular Drug-Eluting Stents(DES) Market Drivers in Global Market
Table 112. Cardiovascular Drug-Eluting Stents(DES) Market Restraints in Global Market
Table 113. Cardiovascular Drug-Eluting Stents(DES) Raw Materials
Table 114. Cardiovascular Drug-Eluting Stents(DES) Raw Materials Suppliers in Global Market
Table 115. Typical Cardiovascular Drug-Eluting Stents(DES) Downstream
Table 116. Cardiovascular Drug-Eluting Stents(DES) Downstream Clients in Global Market
Table 117. Cardiovascular Drug-Eluting Stents(DES) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cardiovascular Drug-Eluting Stents(DES) Segment by Type in 2023
Figure 2. Cardiovascular Drug-Eluting Stents(DES) Segment by Application in 2023
Figure 3. Global Cardiovascular Drug-Eluting Stents(DES) Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cardiovascular Drug-Eluting Stents(DES) Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cardiovascular Drug-Eluting Stents(DES) Revenue, 2019-2030 (US$, Mn)
Figure 7. Cardiovascular Drug-Eluting Stents(DES) Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cardiovascular Drug-Eluting Stents(DES) Revenue in 2023
Figure 9. By Type - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
Figure 11. By Type - Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
Figure 12. By Type - Global Cardiovascular Drug-Eluting Stents(DES) Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
Figure 15. By Application - Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
Figure 16. By Application - Global Cardiovascular Drug-Eluting Stents(DES) Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
Figure 20. By Region - Global Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
Figure 21. By Country - North America Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
Figure 22. By Country - North America Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
Figure 23. US Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
Figure 28. Germany Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 29. France Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
Figure 37. China Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 41. India Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
Figure 43. By Country - South America Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
Figure 44. Brazil Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Cardiovascular Drug-Eluting Stents(DES) Sales Market Share, 2019-2030
Figure 48. Turkey Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Cardiovascular Drug-Eluting Stents(DES) Revenue, (US$, Mn), 2019-2030
Figure 52. Global Cardiovascular Drug-Eluting Stents(DES) Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Cardiovascular Drug-Eluting Stents(DES) by Region, 2023 VS 2030
Figure 54. Cardiovascular Drug-Eluting Stents(DES) Industry Value Chain
Figure 55. Marketing Channels
